We recently conducted a survey of over 143 biopharmaceutical executives to gain real-world perspective on the challenges they face, and shed some light on what motivates them to choose one CRO over another. The results provide insight into several areas:

• The significant challenges companies encounter when conducting preclinical and Phase 1 studies

• The unique difficulties of transitioning from preclinical to first-in-human studies

• The specific capabilities and expertise executives look for in their CRO partners

Listen to this audiobook to hear the results of this survey.

Click here to download a readable, PDF version of this eBook:

https://www.altasciences.com/sites/default/files/2022-04/Biopharma-Dive-Playbook_One-integrated-solution_web.pdf

CHAPTERS:

- 0:16 — Section 1: Introduction

- 1:39 — Section 2: The Drug Development Journey and the Benefits of Outsourcing

- 3:03 - Section 3: Real-World Insights from Our Biopharma Executive Survey

- 6:08 — Section 4: Altasciences Offers Solutions

- 10:34 — Section 5: The One-Stop Solution

About Altasciences:

Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.